Riskpilot← Back to searchSign inGet full accessLuciaklinikken ApS
APSActiveCVR 40811265Albani Torv 4Medical specialists activities · NACE 8622Est. 20191 employees
Revenue 2024
DKK -16K
-57% vs 2023
EBITDA margin
100.0%
+57% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
DKK -266K
-289% vs 2023
| Revenue | DKK -16K | -57% |
| EBITDA | DKK -16K | +57% |
| Net profit | DKK -266K | -289% |
| Total assets | DKK 0 | -100% |
| Equity | DKK -79K | -142% |
| Employees | 1 | — |
Legal name
Luciaklinikken ApS
CVR number
40811265
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
24. september 2019
Share capital
DKK 100.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er klinikvirksomhed, og hermed beslægtet virksomhed. Selskabets formål skal til enhver tid kunne rummes indenfor Den Erhvervsdrivende Fond Luciaklinikkens formål.
Address
Albani Torv 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | -273 | 73 | 0 | -5 | -38 | -16 |
| Staff expenses | -501 | -282 | -0 | -1 | -0 | -0 |
| EBITDA | -774 | -209 | 0 | -11 | -38 | -16 |
| Depreciation & amort. | -1.996 | -48 | -30 | -30 | -30 | -248 |
| EBIT | -2.770 | -257 | -30 | -41 | -68 | -265 |
| Net financials | -0 | 15 | 17 | -0 | 0 | -1 |
| Profit before tax | -2.770 | -242 | -13 | -41 | -68 | -266 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -2.770 | -242 | -13 | -41 | -68 | -266 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 850 | 341 | 348 | 306 | 341 | 0 |
| Equity | 551 | 309 | 296 | 255 | 187 | -79 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 299 | 32 | 51 | 51 | 154 | 79 |
| Total debt | 299 | 32 | 51 | 51 | 154 | 79 |
EBITDA margin
-1641900.0%
This company
15.8%
Market median
-10391872% vs market
20192024
Equity ratio
-7885800.0%
This company
38.2%
Market median
-20643555% vs market
20192024
Return on equity
-26564100.0%
This company
18.4%
Market median
-144370209% vs market
20192024
Net profit margin
-26564100.0%
This company
8.1%
Market median
-327951952% vs market
20192024
Asset turnover
-16419.00×
This company
1.12×
Market median
-1466082% vs market
20192024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-09-24 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
CEMARA ApS | Company | 25.0% | 25.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Luciaklinikken ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ralf Astrup | Board of Directors | 0 companies |
| Jens Nørgaard Oddershede | Board of Directors | 0 companies |